Takeshita Satoshi, Shiono Takaaki, Takagi Ayumu, Ito Takenari, Saito Shigeru
Department of Cardiology, National Cardiovascular Center, Suita, Japan.
Catheter Cardiovasc Interv. 2008 Aug 1;72(2):222-7. doi: 10.1002/ccd.21581.
Percutaneous coronary intervention (PCI) using a guiding catheter with small diameters may have a favorable impact on vascular access complications and patient morbidity. Here, we report the initial results of PCI using a 4-Fr coronary accessor.
A total of 31 patients underwent 4-Fr PCI. Exclusion criteria for 4-Fr PCI were (1) lesions associated with large side branches requiring wire protection or kissing balloon technique and (2) planned use of angioplasty devices which were not compatible with 4-Fr catheter.
A total of 36 lesions, including 4 chronic total occlusions (CTO), were treated. Access sites included radial artery in 19 patients (61%), brachial artery in 8 (26%), and femoral artery in 4 (13%). Four-Fr PCI was successful in 34 of 36 lesions (94%) in 29 of 31 patients (94%). One of the two unsuccessful patients was a case of CTO, and the other a case of tortuous right coronary artery. In both, crossover to a 6-Fr PCI was necessary. Among successfully treated 34 lesions of the 29 patients, coronary stents were deployed in 30 lesions (88%). There were no stent dislodgements or inadequate contrast opacification. No access-site related complications including radial artery occlusion were observed.
PCI with a 4-Fr coronary accessor is a viable alternative to the use of larger guide catheters. The advent of 4-Fr stent delivery system may afford a less invasive approach for the treatment of patients with coronary artery disease.
使用小直径引导导管进行经皮冠状动脉介入治疗(PCI)可能对血管入路并发症和患者发病率产生有利影响。在此,我们报告使用4F冠状动脉接入器进行PCI的初步结果。
共有31例患者接受了4F PCI。4F PCI的排除标准为:(1)与需要钢丝保护或亲吻球囊技术的大侧支相关的病变;(2)计划使用与4F导管不兼容的血管成形术器械。
共治疗了36处病变,包括4处慢性完全闭塞(CTO)病变。入路部位包括19例患者(61%)的桡动脉、8例患者(26%)的肱动脉和4例患者(13%)的股动脉。31例患者中的29例(94%)的36处病变中的34处(94%)4F PCI成功。两名未成功的患者中,一名是CTO病例,另一名是右冠状动脉迂曲病例。在这两例中,均需要改用6F PCI。在29例患者成功治疗的34处病变中,30处病变(88%)植入了冠状动脉支架。没有发生支架移位或造影剂显影不足的情况。未观察到包括桡动脉闭塞在内的与入路部位相关的并发症。
使用4F冠状动脉接入器进行PCI是使用较大引导导管的一种可行替代方法。4F支架输送系统的出现可能为冠心病患者提供一种侵入性较小的治疗方法。